VeriMompolyvinylacetamide은 임신 중 안전한가요?
No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
Related ingredients
Frequently asked questions
- polyvinylacetamide은 임신 중 안전한가요?
- No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- polyvinylacetamide은 모유 수유 중 안전한가요?
- No data found showing transfer to breast milk or adverse effects during lactation for polyvinylacetamide. No authoritative safety assessment (CIR/SCCS/harmonised CLP) raising reproductive/lactation concerns was identified; therefore default scoring is 0. Potential concern would relate to residual monomer (N‑vinylacetamide) if present, but no data on levels or breast‑milk transfer were located. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- polyvinylacetamide은 아기 피부에 안전한가요?
- No evidence of developmental or infant‑specific hazard was found. For exposure (e) infants have a less mature skin barrier and higher surface‑area‑to‑weight ratio; polymers like poly(N‑vinylacetamide) are generally of low dermal absorption, so adult exposure is negligible (e=0) but infant exposure is increased to e=1 to reflect higher potential per‑weight exposure and possibility of measurable absorption if small amounts of low‑molecular‑weight species (residual monomer) are present. There is no infant‑specific toxicology showing increased hazard. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Poly%28N-vinylacetamide%29?utm_source=openai))
- VeriMom은 polyvinylacetamide을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 polyvinylacetamide을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 polyvinylacetamide 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.